Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy
Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy
复制标题
DOI:
10.1161/circulationaha.105.583500
复制
发表时间:
2006-07-18
期刊:
影响因子:
37.8
通讯作者:
Maron, Barry J.
中科院分区:
文献类型:
--
作者:
Harris, Kevin M.;Spirito, Paolo;Maron, Barry J.
Background - End stage (ES) is a recognized part of the hypertrophic cardiomyopathy (HCM) disease spectrum. Frequency, clinical profile and course, and treatment strategies in these patients remain incompletely defined.Methods and Results - Three HCM cohorts comprised 1259 patients, including 44 (3.5%) characterized as ES with systolic dysfunction (ejection fraction < 50% at rest; range 15% to 49%). ES developed at a wide age range (14 to 74 years), with 45% of patients